Literature DB >> 2465385

1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex.

J C Marvizón1, A H Lewin, P Skolnick.   

Abstract

1-Aminocyclopropane carboxylic acid (ACPC) competitively inhibited (IC50, 38 +/- 7 nM) [3H]glycine binding to rat forebrain membranes but did not affect [3H]strychnine binding to rat brainstem/spinal cord membranes. Like glycine, ACPC enhanced 3H-labelled (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate ([3H]MK-801) binding to N-methyl-D-aspartate receptor-coupled cation channels (EC50, 135 +/- 76 nM and 206 +/- 78 nM for ACPC and glycine, respectively) but was approximately 40% less efficacious in this regard. The maximum increase in [3H]MK-801 binding produced by a combination of ACPC and glycine was not different from that elicited by glycine, but both compounds potentiated glutamate-stimulated [3H]MK-801 binding. These findings indicate that ACPC is a potent and selective ligand at the glycine modulatory site associated with the N-methyl-D-aspartate receptor complex.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2465385     DOI: 10.1111/j.1471-4159.1989.tb02554.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  A review of the in vitro and in vivo neurochemical characterization of the NMDA/PCP/glycine/ion channel receptor macrocomplex.

Authors:  P L Wood; T S Rao; S Iyengar; T Lanthorn; J Monahan; A Cordi; E Sun; M Vazquez; N Gray; P Contreras
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor.

Authors:  G Henderson; J W Johnson; P Ascher
Journal:  J Physiol       Date:  1990-11       Impact factor: 5.182

3.  Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex.

Authors:  P Skolnick; R Miller; A Young; K Boje; R Trullas
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Different specific binding sites of [3H]glycine and [3H]strychnine in synaptosomal membranes isolated from frog retina.

Authors:  J A Pérez-León; R Salceda
Journal:  Neurochem Res       Date:  1995-08       Impact factor: 3.996

5.  3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.

Authors:  Alessia Scatena; Francesco Fornai; Maria Letizia Trincavelli; Sabrina Taliani; Simona Daniele; Isabella Pugliesi; Sandro Cosconati; Claudia Martini; Federico Da Settimo
Journal:  ACS Chem Neurosci       Date:  2011-06-10       Impact factor: 4.418

6.  Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists.

Authors:  I A Paul; R Trullas; P Skolnick; G Nowak
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Effect of 1-aminocyclopropanecarboxylic acid on N-methyl-D-aspartate-stimulated [3H]-noradrenaline release in rat hippocampal synaptosomes.

Authors:  M V Clos; A Garcia Sanz; R Trullas; A Badia
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

8.  The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex.

Authors:  P Popik; R T Layer; P Skolnick
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

9.  D-Cycloserine: Agonist turned antagonist.

Authors:  T H Lanthorn
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

10.  1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats.

Authors:  Piotr Popik; Malgorzata Holuj; Agnieszka Nikiforuk; Tomasz Kos; Ramon Trullas; Phil Skolnick
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.